Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.98−0.06 (-5.77%)
Close on Nov 17, 2026Market cap $12.10MP/E –Yield –
Pluri gross margin
Gross margin is gross profit as a percentage of revenue.
Pluri's gross margin for the twelve months ending Jun 30, 2026 was 44.6%. For fiscal 2026 it was 44.6%, against 49.0% the year before. The highest annual figure on record is 100.0% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 44.6% | −4.4 |
| FY2025 | Jun 30, 2025 | 49.0% | −49.8 |
| FY2024 | Jun 30, 2024 | 98.8% | +1.9 |
| FY2023 | Jun 30, 2023 | 96.9% | −3.1 |
| FY2022 | Jun 30, 2022 | 100.0% | +0.0 |
| FY2020 | Jun 30, 2020 | 100.0% | +3.7 |
| FY2019 | Jun 30, 2019 | 96.3% | +0.3 |
| FY2018 | Jun 30, 2018 | 96.0% | −0.5 |
| FY2016 | Jun 30, 2016 | 96.5% | −0.1 |
| FY2015 | Jun 30, 2015 | 96.6% | −0.5 |
| FY2014 | Jun 30, 2014 | 97.1% | +0.0 |
| FY2013 | Jun 30, 2013 | 97.1% | −0.0 |
| FY2012 | Jun 30, 2012 | 97.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 58.5% | +6.5 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 33.5% | +1.7 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 43.4% | −16.6 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 36.4% | −25.0 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 52.0% | −43.8 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 31.9% | −68.1 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 60.0% | −40.0 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 61.3% | −38.7 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 95.8% | +0.2 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 100.0% | +4.0 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | 100.0% | +0.0 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | 100.0% | +4.0 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 95.7% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 96.0% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 100.0% | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 96.0% | – |
See a number that looks wrong?